Brain Scientific (OTCQB: BRSF) co-founder and executive chairman Boris Goldstein was quoted in a recent Elite Healthcare article titled “A Look at 2021 Healthcare with the Pandemic.” The article quoted a variety of clinicians and industry professionals who consider themselves futurists and who specialize in exploring predictions and possibilities based on present trends. The article discussed health care in 2021 from a variety of standpoints including individualized healthcare, technology timelines, conducting clinical trials, emerging emergency response, pediatric parameters, and facility design and work flows. Some trends were obvious, such as the dramatic growth of telehealth and various Internet of Medical Things; the expected increase of depression and anxiety was also noted. In addition, the article mentioned that augmented reality, or a 3D interactive experience in which objects in real-world environments are enhanced by computer-generated perception, is already being used in health-care facilities around the world. “COVID-19 put a spotlight on the outdated and inefficient EEG (‘EEG’) testing protocols,” said Goldstein in the article; he also noted that he sees an immediate shift to technologies that allow for faster and more reliable testing techniques, alongside the use of AI for the secure transfer of patient data. “Disposable technology made a significant impact to ensure brain scans could occur safely during the pandemic,” he continued. “Now, brain e-tattoos implanted in the forehead will be the next wave of innovation for neurology. The advancement will allow for long-term monitoring capabilities and uninterrupted data collection from patients with neurological conditions. Clinicians will be able to identify brain wave activity beyond the clinical setting with no impact to the patient’s daily life.”
To view the full article, visit https://ibn.fm/Tlrsw
About Brain Scientific
Brain Scientific is a commercial-stage, health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. For more information about this company, please visit www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.